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Abstract 
Background: The non-medical use of prescription stimulants (NMUPS) is one of the most 
prevalent illicit behaviors on college campuses. While numerous risk factors for NMUPS have 
been identified, it is unknown how non-using students who meet several risk factors for NMUPS 
differ from those who have used, which may inform intervention efforts. We expected that users 
would evidence greater cognitive enhancement and anxiety/arousal expectancies and intentions 
to use, and lower guilt/dependence expectancies, perceptions of NMUPS-related harm, and 
academic self-efficacy. Methods: Between 2014-2016, students (N=121; 65% female) at two 
demographically dissimilar colleges in the Northeastern and Midwestern United States who 
reported lifetime NMUPS or endorsed two or more NMUPS risk factors (i.e., recent marijuana 
use, recent binge drinking, grade point average <3.5, Greek-life involvement, male gender) 
reported on their prescription stimulant expectancies; academic self-efficacy; perceived harm of 
NMUPS; lifetime NMUPS; and intentions for NMUPS in the next six months. Results: A 
MANCOVA showed that at-risk non-users had lower cognitive expectancies, higher 
guilt/dependence expectancies, and higher anxiety/arousal expectancies compared to users. 
ANCOVAs and Chi-square tests showed that non-users also perceived NMUPS to be more 
harmful and were less likely to divert their medication if prescribed. The groups did not differ on 
academic self-efficacy or total number of risk factors endorsed. However, recent marijuana use 
was more prevalent in users. Conclusions: Targeted preventive interventions for NMUPS should 
focus on students who are using marijuana and should aim to maintain lower positive and higher 
negative stimulant expectancies and reaffirm potential NMUPS-related harms.  
Keywords: prescription stimulants; expectancies; academic self-efficacy; perceived harm; 
marijuana use; diversion; college students 
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Glossary 
 
1. diversion: endorsement of selling or giving away one’s prescribed stimulant medication 
 
2. expectancies: cognitions about a drug’s expected effects 
 
3. non-medical use of prescription stimulants: the use of prescription stimulants like Adderall,  
 
Ritalin, or Concerta without a prescription, or in ways other than prescribed   
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Factors that Differentiate Prescription Stimulant Misusers from those At-Risk for Misuse:   
Expectancies, Perceived Safety, and Diversion  
 Non-medical prescription stimulant use [NMUPS; i.e., the use of prescription stimulants 
like Adderall, Ritalin, or Concerta without a prescription, or in ways other than prescribed 
(NIDA, n.d.)] has been increasing in college students (McCabe, West, Teter, & Boyd, 2014), 
with nearly one-third or more of the student body reporting NMUPS in some studies (Advokat, 
Guidry, & Martino, 2008; DeSantis, Webb, & Noar, 2008; Garnier-Dykstra, Caldeira, Vincent, 
O’Grady, & Arria, 2012). Specific motives for use predominantly include cognitive enhancement 
purposes, such as increasing concentration and alertness, though recreational and appetite-
suppression motives also have been reported (Barrett et al., 2005; Kilwein, Goodman, Looby, & 
De Young, 2016; Low & Gendaszek, 2002; Teter, McCabe, Cranford, Boyd, & Guthrie, 2005). 
Despite these expected benefits of use, high doses of stimulant medication are linked to higher 
body temperatures, paranoia, and cardiovascular complications (NIDA, n.d.), and a survey of 
undergraduates found that over half of students reported experiencing other maladaptive 
outcomes such as appetite loss, sleep problems, irritability, and headaches at least “sometimes” 
following use (Rabiner et al., 2009). Furthermore, NMUPS is associated with more frequent 
illicit drug use (Arria, Caldeira, O’Grady, Vincent, Johnson, & Wish, 2008). For example, 
McCabe and Teter (2007) found that college students who engaged in NMUPS were over four 
times more likely than nonusers to engage in polydrug use. These students also were more likely 
to report drug-related problems, such as engaging in illegal activities to obtain drugs, withdrawal 
symptoms from other drugs, drug-related medical problems, and drug-related family conflict. 
Consequently, identification of risk factors for NMUPS among college students is warranted in 
an effort to decrease these negative consequences.    
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A recent review of 30 studies on NMUPS highlighted several risk factors for NMUPS, 
including male gender, Greek-life involvement, lower (<3.5) grade point average (GPA, and 
heavy drinking and/or marijuana use (see Benson, Flory, Humphreys, & Lee, 2015). Recent 
research also has identified a host of psychological risk factors that are potentially modifiable 
through intervention. For example, NMUPS has been associated with executive function deficits 
(Munro, Weyandt, Marraccini, & Oster, 2017), ADHD symptoms (Benson et al., 2015), 
depression (Teter, Falone, Cranford, Boyd, & McCabe, 2010), and anxiety (Dussault & 
Weyandt, 2013; Verdi, Weyandt, & Zavras, 2016).   
An additional psychological variable under study that has promise as a target of 
intervention for NMUPS is expectancy effects (Looby & Earleywine, 2009; 2010; Looby, De 
Young, & Earleywine, 2013). Expectancies, or cognitions about a drug’s expected effects, are 
known to be influential in the decision to use various substances including alcohol, marijuana, 
and cocaine (Cox & Klinger, 1988; Goldman, Brown, Christiansen, 1987; Schafer & Brown, 
1991); thus, they also should help differentiate at-risk prescription stimulant nonusers from users. 
Indeed, Looby and Earleywine (2009, 2010) showed that positive cognitive enhancement 
expectancies (e.g., enhanced focus and concentration) predicted frequency of non-medical use 
Similarly, Lookatch, Dunne, and Katz (2012) reported that self-generated positive expectancies 
(e.g., improved concentration, ability to stay up and study) and more positive evaluations of 
those effects were associated with a greater likelihood of NMUPS. On the other hand, negative 
prescription stimulant expectancies, such as concerns about addiction or using these drugs as a 
“shortcut”, were far more common among nonusers (Looby & Earleywine, 2010); nonusers also 
provided more negative subjective evaluations of self-generated negative expectancies (e.g., 
feeling jittery) (Lookatch et al., 2012). Interestingly, Looby and Earleywine (2010) found that 
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expectations for physiological arousal and anxiety were significantly higher among recreational 
users compared to medical users without a history of misuse, suggesting that users anticipate 
differential negative psychological and physiological effects.. A better understanding of how 
expectancy effects influence NMUPS, and importantly, how they differ between users and at-risk 
nonusers, may assist in the development of brief, group-based interventions (e.g., expectancy 
challenges; Darkes & Goldman, 1993).   
Other cognitive and behavioral factors that might differentiate at-risk nonusers from users 
and that could be targeted in brief group-based interventions with college students include 
academic self-efficacy, intentions to use, perceived safety of prescription stimulants, and 
diversion of prescription stimulants. Looby, Beyer, and Zimmerman (2015) found that 
undergraduate students who were less confident in their ability to handle academic challenges 
reported a greater likelihood of use, though an association between lower academic self-efficacy 
and use was not found among a sample of graduate students (Verdi et al., 2016). Further, 
intentions to use were a robust predictor of NMUPS in three models examining interpersonal, 
social/contextual, and sociocultural risk factors (Bavarian, Flay, Ketcham, & Smit, 2013). 
Additionally, both perceived safety of prescription stimulants (Verdi et al., 2016; Weyandt et al., 
2009) and medication diversion (e.g., Sepulveda et al., 2011) were associated with NMUPS. 
Although these constructs have been identified, little research has examined their role in at-risk 
but non-using students, who are likely targets of preventative intervention.  
Accordingly, the current study extended previous research by examining modifiable 
cognitive and behavioral risk factors of students at-risk for NMUPS compared to those who have 
progressed to use. Specifically, we sought to determine whether non-using students at-risk for 
NMUPS could be differentiated from NMUPS users based on their expectancies, perceptions of 
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NMUPS harm, academic self-efficacy, and intentions to use. Based on prior research, we 
hypothesized that compared to at risk non-users, users would have higher cognitive enhancement 
and anxiety/arousal expectancies, lower guilt/dependence expectancies, and greater perceived 
safety of prescription stimulants. We also expected users to endorse lower academic self-
efficacy, stronger intentions to use in the next six months, and a higher prevalence of diverting 
one’s stimulants (if prescribed). The identification of cognitive and behavioral factors that 
distinguish these groups can direct prevention and intervention efforts (e.g., expectancy 
challenges, psychoeducation, study skills interventions) to reduce use and associated negative 
consequences among college students.   
Method 
Participants and Procedure 
Participants were 121 college students (65% female; Mage=20.14, SD=1.87); 
approximately two-thirds (64%) were enrolled at a small, private college in the Northeast and 
36% attended a large, public university in the Midwestern United States. Participants identified 
primarily (86%) as Caucasian. The remainder identified as: 6% Black/African American; 3% 
Hispanic/Latino; 2% Asian/Pacific Islander; 2% Other; and 1% American Indian/Native 
American. Participants were from all class years (31% first-years, 28% sophomores, 17% 
juniors, and 23% seniors) and 20% endorsed being a member of a Greek organization. The 
majority of participants (77%) reported a grade point average of a B (i.e., 3.0 on 4.0 scale) or 
higher. Education levels of the participants’ parents were relatively high: 32% of fathers had 
some graduate school or obtained a graduate degree and 53% had some college or a college 
degree. Similarly, 29% of mothers had some graduate school or a graduate degree and 58% had 
some college or a college degree.  
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Students were recruited via presentations in Psychology courses, flyers posted on 
campus, and the Introductory Psychology pools at both institutions. Students were provided with 
a brief description of the study (i.e., “Attitudes about Study Drugs”) and the web address of the 
screening survey. Interested students completed the brief online screening survey, in which they 
reported on whether they had ever used stimulants non-medically during their lifetime (or, if they 
were prescribed, if they had ever used more than was prescribed), gender, GPA, involvement in 
Greek life, and recent binge drinking (past two weeks) and marijuana use (past month). Students 
who endorsed lifetime NMUPS, or at least two of five risk factors for NMUPS (i.e., male gender, 
GPA<3.5, member of Greek life, past month marijuana use, or past two-week binge drinking) 
were invited by a research assistant via e-mail to participate in small group sessions (see below). 
Although a host of risk factors for NMUPS have been identified, we focused on the 
aforementioned demographic risk factors because they have appeared most consistently in the 
literature on NMUPS (see Benson et al., 2015 for a review). We focused on recent alcohol and 
cannabis use as well, given the robust findings in the literature linking NMUPS and other 
substance use (e.g., Arria et al., 2008; McCabe, Knight, Teter, & Wechsler, 2005). We 
considered students “at-risk” for NMUPS if they possessed two or more of these risk factors, 
both to be consistent with previous research that utilized this cutoff and recruited a sample with a 
relatively high incidence rate over six months (Looby, DeYoung, & Earleywine, 2013), and 
because we expected this threshold would permit the inclusion of a wide range of students, while 
not overpathologizing one behavior (e.g., binge drinking) or demographic characterstic. A small 
percentage of students who endorsed NMUPS in the current study (17%) reported only one risk 
factor or no risk factors; however, given that only 55% of users endorsed three of more risk 
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factors, moving to a higher threshold likely would have excluded numerous students who, 
ultimately, might engage in NMUPS.  
Data for the current study were collected as part of the baseline survey for a larger group-
based intervention study. Participants met in small groups (~6 students) in private rooms on 
campus, with 1-2 college student facilitators, and completed the baseline survey on individual 
laptop computers, provided they first consented to the study procedures. Participants received 
course credit, extra credit, or a small monetary payment ($5) for participating. The Institutional 
Review Boards at each institution approved the study.      
Measures 
 Expectancies. The 45-item Prescription Stimulant Expectancy Questionnaire II (Looby 
& Earleywine, 2010) examined positive and negative effects that participants would anticipate if 
they engaged in NMUPS. The 20-item cognitive enhancement subscale examined expectations 
for improved focus, concentration, and greater work enjoyment. The 11-item anxiety and arousal 
subscale inquired about expected adverse physiological effects (e.g., heart racing), and the 5-item 
guilt and dependence subscale examined concerns about addiction and using stimulants as a 
“crutch.” We excluded the 9-item social enhancement subscale because it was not relevant to our 
study’s hypotheses. Previous research on the PSEQ-II showed that the internal consistencies of 
each of the subscales were fair to excellent and that each scale evidenced good convergent 
validity with current and intended prescription stimulant misuse (Looby & Earleywine, 2010). 
Internal consistencies in our study were nearly identifical to those obtained by Looby and 
Earleywine (2010): cognitive enhancement (=.95), anxiety/arousal (=.88), and 
guilt/dependence (=.75). A five-point response scale was used (1=never, 5=very often). Mean 
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scores were calculated for each of the three expectancy scales, respectively; higher mean scores 
denoted more expected effects in that domain.   
 Academic self-efficacy. The 14-item study subscale from the Self-Efficacy for Learning 
Form (Zimmerman & Kitsantas, 2005) assessed students’ ability to implement learning strategies 
(e.g., reword complex definitions), manage distractions and refocus their attention, utilize their 
study time effectively, and adapt to course preparation challenges. The SELF has demonstrated 
good predictive validity and excellent reliability in previous research (Zimmerman & Kitsantas, 
2005); further, the study subscale of the SELF has demonstrated good reliability in previous 
research with college students (Looby et al., 2014).  Responses ranged from 0=definitely cannot 
do it to 100= definitely can do it. We calculated a mean score from the 14 items, with higher 
mean scores denoting greater academic self-efficacy. 
 Perceived safety. Two items inquiring about perceived harmlessness of daily or 
occasional NMUPS from the Stimulant Survey Questionnaire (Weyandt et al., 2009) were 
averaged to produce a mean perceived safety score. The reliability of this brief scale was 
somewhat low (=.59), but similar to previous research employing a six-item scale (=.61; 
Weyandt et al., 2009). A five-point response scale (1=never, 5=always) was used, with higher 
mean scores denoting less concern about NMUPS. 
 Risk factor assessment, ADHD diagnosis, diversion, and intentions. We created a 
total risk factor score by summing the number of risk factors participants endorsed on the 
screening survey [i.e., male gender, GPA<3.5, Greek life involvement, marijuana use in the last 
month, and binge drinking in the past two weeks (i.e., four drinks in two hours for females, five 
drinks for males]. We asked whether participants had ever used stimulants without a prescription 
(or more than was prescribed if they had a prescription) and whether prescribed participants had 
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ever given away or sold their medication. To assess intentions for NMUPS in the next six 
months, we adapted a question about intentions to drink from LaBrie, Quinlan, Schiffman, and 
Earleywine (2005); students responded on a 0 (definitely no)-100 (definitely yes) scale.  
Data Analysis 
 To determine whether there were differences between students who had used stimulants 
non-medically and those who had not, we first used a multivariate analysis of covariance 
(MANCOVA) with the three expectancy variables as outcomes, user status (user vs. nonuser) as 
the independent variable, and site as a covariate. For the remaining continuous study variables 
(academic self-efficacy, perceived harmlessness, sum of NMUPS risk factors, intentions to use), 
we used an analysis of covariance (ANCOVA) for each variable, respectively. We controlled for 
site in the MANCOVA and ANCOVAs, since preliminary tests showed that participants at the 
Northeast site endorsed higher academic self-efficacy and more risk factors overall. We report 
estimated marginal means (EMM), which were adjusted for site.  
Since chi-square tests did not reveal any differences between the two sites for the 
demographic variables or the categorical outcome variables (i.e., binge drinking, marijuana use, 
students with ADHD diagnosis, diversion), we used chi-square tests to compare users and non-
users on these constructs without adjusting for site differences. We used .05 as the alpha level for 
all statistical tests. 
Results 
Demographic Characteristics and Risk Factor Endorsement by User Group  
More than half of participants (n=71; 59%) reported NMUPS at some point in their 
lifetime and constituted the “user” group. The remainder (n=50, 41%) endorsed two or more risk 
factors, but denied lifetime NMUPS; thus, they were classified as “at-risk nonusers”. Chi-square 
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tests showed that there were no demographic differences between at-risk non-users and users, 
with the exception of fewer users reporting involvement in Greek life compared to nonusers 
[13% vs. 32%; 2(1,120) = 6.48, p = .01]. An ANCOVA (controlling for site) showed that the 
two groups did not differ with respect to the mean number of risk factors they endorsed 
[EMMnon-users=2.53, SE=0.13 vs. EMMusers=2.50, SE=0.11; F(1,118) = 0.02, p = .886]. However, 
chi-square tests showed that users were more likely than nonusers to endorse marijuana use in 
the past month [30% vs. 58%; 2(1,121) = 9.09, p = .003]. Table 1 provides comprehensive 
demographic information for each group and their endorsement of recent alcohol and marijuana 
use.     
Differences in Expectancies and Perceived Harmlessness  
Our findings related to the three expectancy variables and perceived harmlessness largely 
were consistent with our hypotheses. A MANCOVA showed that, after controlling for site, users 
endorsed significantly higher cognitive enhancement expectancies, F(1,117) = 7.29, p = .008, p2 = 
0.06, and lower guilt/dependence expectancies, F(1,117) = 16.38, p < .001, p2 = 0.12, as predicted. 
Our next hypothesis, namely that users would endorse higher anxiety/arousal expectancies, was 
not supported; in fact, users reported significantly lower expectancies in this domain, F(1,117) = 
9.83, p = .002, p2 = 0.08. As expected, an ANCOVA showed that users were more likely to 
perceive NMUPS as harmless, F(1,117) = 14.27, p < .001, p2 = 0.11. Figure 1 displays the means 
associated with each outcome above by user group.   
Differences in Intentions To Use, Diversion, and Academic Self-Efficacy 
Consistent with our hypotheses, an ANCOVA showed that users reported greater 
NMUPS intentions in the next six months, F(1,117) = 57.35, p < .001, p2 = 0.33, and a chi-square 
test showed they were more likely to divert their medication (if prescribed): 2(1,25) = 8.36, p = 
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.004. Contrary to our hypothesis, an ANCOVA showed that academic self-efficacy scores did 
not differ between users and nonusers, F(1,118) = 1.43, p = .234. Figure 2 displays mean academic 
self-efficacy scores, mean intentions scores, and the percentage of prescribed students who 
endorsed diverting stimulant medication by user group.    
Discussion 
 This study sought to provide a nuanced comparison of prescription stimulant users and 
non-users, focusing on the potentially modifiable cognitive and behavioral risk factors of an at-
risk sample. Previous research with large, heterogeneous samples consistently identified several 
key demographic risk factors (e.g., male gender, GPA), though many of these factors are not 
amenable to intervention. While more recent research has examined modifiable risk factors (e.g., 
expectancy effects, self-efficacy), it provides little guidance around how to intervene with 
students who are at-risk but have not yet initiated NMUPS. The present results add to the 
literature on risk factors for NMUPS by highlighting potential targets of intervention specifically 
for college students at-risk for NMUPS initiation.  
In the current study, users and at-risk non-users largely were distinguished by their 
NMUPS-related beliefs and recent marijuana use. Consistent with previous research, users 
reported greater cognitive enhancement and lower guilt/dependence expectancies (Looby & 
Earleywine, 2010), greater perceived safety (Weyandt et al., 2009), greater likelihood of 
diversion (Sepulveda et al., 2011), and stronger intentions to use (Bavarian et al., 2013). 
Contrary to Looby and Earleywine (2010), users were less likely to endorse anxiety/arousal 
expectancies, suggesting that concerns about stimulant-related physiological effects may be a 
protective factor among students at-risk. The lack of difference in academic self-efficacy also 
contradicted previous research with undergraduates (Looby et al., 2015). Since 77% of our 
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sample reported a lower GPA (< 3.5), and lower GPA and academic self-efficacy were inversely 
correlated (r = -.22, p < .05), academic self-efficacy might have been especially low in our 
sample, rendering it less able to differentiate user groups.         
Combined with prior research, results from the current study provide an outline for the 
development of a comprehensive targeted intervention for college students at-risk for NMUPS. 
As group differences in NMUPS-related expectancy effects have now been demonstrated across 
several studies (e.g., Looby & Earleywine, 2009; 2010), expectancy modification may be a 
particularly important component, especially related to both weakening positive cognitive 
enhancement expectancies and strengthening negative expectancies. Given that cognitive 
enhancement expectancies were higher among users, and also that recent research suggests 
limited prescription stimulant-related cognitive enhancement among healthy adults (e.g., 
Cropsey et al., 2017; Ilieva, Boland, & Farah, 2013; Marraccini, Weyandt, Rossi, & 
Gudmundsdottir, 2016; Weyandt et al., 2016), challenging these beliefs may reduce the 
incidence of NMUPS if students no longer expect substantial benefit from the medication.  
Alternatively, providing students with alternate and safer means of enhancing cognition 
or providing instruction in study skills may assist students in achieving their cognitive 
enhancement goals. However, it is clear that an effective intervention also must work to 
strengthen belief in the negative effects of NMUPS, as users in the present study reported weaker 
negative expectancies and higher perceived safety of use. In prior work, a single randomized-
controlled trial of an expectancy challenge intervention focused on weakening cognitive 
enhancement expectancies for NMUPS successfully modified expectancies but ultimately did not 
reduce NMUPS initiation (Looby et al., 2013); thus, a more comprehensive intervention that 
reduces cognitive enhancement expectancies and intensifies guilt/dependence and 
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anxiety/arousal expectancies may be needed. Students could be encouraged to elaborate on the 
personal significance of their negative expectancies and how prescription stimulants could 
endanger their future goals (Steiger, Stoddard, & Pierce, 2017). Indeed, a similar type of 
intervention reduced risky drinking in college students (LaBrie, Pedersen, Earleywine, & Olsen, 
2006). Finally, at-risk students with prescriptions should be advised not to disclose their 
prescription to peers, thereby reducing their risk of being approached and being exposed to 
recreational stimulant users. With regard to targeting students who may particularly benefit from 
preventative intervention, non-users endorsing recent marijuana use should be prioritized, as 
their substance use may be compromising their academic engagement, making them more prone 
to seek out stimulants as a “compensatory last ditch attempt to improve grades” (Arria et al., 
2017, p. 246). This type of multi-faceted approach may be one way to counteract the rising tide 
of NMUPS.      
 Some limitations are of note. Given our modest sample size, we utilized a dichotomous 
NMUPS measure, which precluded us from making distinctions among students based on 
different patterns of prescription stimulant misuse (i.e., low vs. high frequency use). Similarly, to 
ensure a robust sample size of users, we grouped medical misusers (i.e., using more than 
prescribed when one has a prescription) with recreational users (i.e., using prescription 
stimulants without a prescription). Future research with a larger sample and a more detailed 
assessment of prescription stimulant misuse frequency/quantity would allow us to better 
characterize students across a wider range of use patterns, which ultimately might lead to more 
targeted interventions that not only prevent NMUPS, but the escalation of use once it has been 
initiated. Our modest sample size also precluded us from detecting small and small-to-medium 
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effects (Faul, Erdfelder, Lang, & Buchner, 2007); replicating this study with a larger sample 
would permit the identification of these effects if they were present.  
Other limitations include the fact that our conceptualization of which students were “at-
risk” for NMUPS was limited by the five risk factors we selected. Future studies might 
characterize an “at-risk” group using different NMUPS-related risk factors, establish a more 
stringent cutoff (e.g., three risk factors), or screen students for specific constellations of risk 
factors, to ensure that students who are identified are prime candidates for a preventive 
intervention. Further, because our study was correlational, we cannot assert a causal role between 
use and patterns of assessed risk factors. For example, it is unknown whether or how users’ 
expectancies may have changed as a consequence of their use. Future research should employ 
longitudinal methodology to examine changes in modifiable risk factors as a function of 
initiating use and progressing to more frequent use. Finally, results from this study were obtained 
from predominantly White undergraduate students and the sample was heavily female; thus, 
results may not generalize to male students from more diverse institutions, or to high school or 
graduate students.   
 Overall, this study adds to the current research on risk factors for NMUPS and highlights 
areas of intervention for college students most at risk for engaging in this behavior. Despite the 
increasing rates of use among college students, little work has been devoted to preventative 
measures. As positive and negative expectancy effects and perceptions of safety differ between 
user groups, the efficacy of interventions that modify these beliefs should be examined. Further 
research into modifiable risk factors for NMUPS is necessary to continue to identify targets of 
intervention that can be included as components of a comprehensive intervention program.  
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Table 1 
Comparison of At-Risk Nonusers and Users on Demographic and Screening Measures 
 
 
Characteristic 
  
At-Risk Nonusers 
(n=50) 
  
Users 
(n=71) 
 
Full sample 
(N=121) 
Gender 
Female  
Male 
 
70% 
30% 
 
61% 
39% 
 
65% 
35% 
Race/ethnicitya 
White/non-Hispanic 
African American/Black 
American Indian/Native American 
Asian/Pacific Islander 
Hispanic/Latino/a 
Other 
Class yeara 
Freshman 
Sophomore 
Junior  
Senior 
 
86% 
 8% 
 0%  
4% 
 2% 
 0% 
 
38% 
30% 
14% 
18% 
 
 
86% 
  4% 
  1%   
  1% 
  4% 
  3% 
 
27% 
27% 
20% 
27% 
 
 
86% 
6% 
1% 
2% 
3% 
2% 
 
31% 
28% 
17% 
23% 
 
Endorsed Greek membership* 
 
Type of high school attended 
     Private 
     Public 
     
Grade point average 
<2.50 
2.50-2.99 
3.00-3.49 
>3.50 
 
ADHD diagnosis 
 
Other substance use 
    Binge drinking prior 2 weeks 
    Past month marijuana use** 
 
Total number of risk factors (M, SE) 
32% 
 
 
28% 
72% 
 
 
12% 
14% 
50% 
24% 
 
18% 
 
 
78% 
30% 
 
2.53 (0.13) 
13% 
 
 
28% 
72% 
 
 
  3% 
18% 
52% 
27% 
 
27% 
 
 
70% 
58% 
 
2.50 (0.11) 
21% 
 
 
28% 
72% 
 
 
 7% 
16% 
51% 
26% 
 
23% 
 
 
73% 
46% 
 
2.51 (0.90) 
Note. aBecause of rounding, percentages add up to less (or more) than 100. Estimated marginal 
means and standard errors are reported for total number of risk factors; the mean and standard 
deviation is listed for the full sample.     
*p = .01 
**p < .01 
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Figure 1. Comparison of at-risk nonusers with users on expectancies and perceived safety of 
occasional or daily non-medical use. Estimated marginal means are depicted, with standard 
errors. All ps < .01.  
  
1
1.5
2
2.5
3
3.5
4
Cognitive
enhancement
Guilt and
dependence
Anxiety and
arousal
Perceived safety
M
ea
n
 S
co
re
Non-users Users
DIFFERENTIATING STIMULANT NONUSERS FROM USERS                  
 
25
 
Figure 2. Comparison of at-risk nonusers with users on academic self-efficacy mean score 
(estimated marginal means with standard errors), NMUPS intentions mean (estimated marginal 
means with standard errors), and frequency of diversion (percent) among participants with a 
stimulant prescription.  
*p < .01, **p < .001  
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